Gadobutrol - Wikipedia
https://en.wikipedia.org/wiki/Gadobutrol
OverviewHistoryMedical usesAdverse effectsUse in specific populationsInteractionsMechanism of actionGadobutrol was first approved in Switzerland in 1998 for use in contrast-enhanced MRI scans of the brain and spinal cord. Since then, it has been approved and marketed in 65 other countries including all European Union countries, the United States, Canada, Mexico, Australia, New Zealand, China, South Korea, Russia, and Brazil, for a multitude of uses. Gadobutrol was first approved for use in MRIs of the central nervous system in the United States in 2011. It is current… Routes of administration: IV: Molar mass: 604.72 g·mol−1 Formula: C₁₈H₃₁GdN₄O₉
Routes of administration: IV:
Molar mass: 604.72 g·mol−1
Formula: C₁₈H₃₁GdN₄O₉
DA: 56 PA: 34 MOZ Rank: 65